Chronic Wound Care
Existing wound care products have limitations such as slow hemostasis, significant pain, delayed healing, risk of infections, require multiple procedures, discoloration, scarring, and wound complications.
All of these challenges can be effectively addressed with BloodSTOP® iX Advanced Hemostat with WoundHEAL®.
Why use BloodSTOP® iX for chronic wound treatment?
BloodSTOP iX addresses the issue of long healing time in wounds such as diabetic foot ulcers, leading to higher risk of amputations. The median time in healing diabetic foot ulcers without surgery is usually 84 days as compared to only 21 days for skin to regenerate after application of BloodSTOP iX as shown in a histology report (Figure 3).
Figure 1. After debridement
Figure 2. Hemostasis with BloodSTOP iX gel
Figure 3. Healing with BloodSTOP iX
BloodSTOP iX functions in:
Providing rapid hemostasis for acute and chronic wounds
Facilitating fast healing in ulcer wounds after debridement
Sealing the wound as it turns into a gel upon contact with blood and exudate, protecting wounds, and preventing contamination
Facilitating proliferation of new skin growth within 7 days on donor sites and skin grafts in full-thickness burns (American Burn Association 2019 Best-in-Category Award Winner)
Preventing production of excessive exudates
- Pressure Ulcers
- Vascular Ulcers
- Neuropathic Ulcers (e.g., Diabetic Foot Ulcers)
- Other Chronic and Acute Wounds
Diabetic Ulcer Wound
Genetic Skinless Disorder
A 9-year-old girl with skinless wounds across scalp, abdomen, and legs (a genetic disorder) was in the care of Dr. Ibrahim Amjad. She always bled over 500 cc of blood in the last 2 years, requiring transfusion of 2 units of blood at every OR visit. Multiple treatments of open wounds of the scalp, abdomen and legs were attempted in the last 2 years using Sulfamylon, Aquacel AG, Silvadene, and Gentian Violet with no success.
Ibrahim Amjad, MD, FCAS, a plastic surgeon at Miami Children’s Hospital worked on the 9-year-old in the next 30 days using BloodSTOP iX (with 3 times a week BloodSTOP iX applications) and saw new skin growth.
With the introduction of BloodSTOP iX, wound debridement was performed, reducing blood loss by less than 200 cc and only requiring one unit or a partial unit of blood transfusion.
Any type of debridement and cleaning of her wounds would not have been possible at one OR sitting without the use of BloodSTOP iX.